Cancer related Fatigue Interventio

Not Applicable

• Conditions: oncological diseases; C00-C97; Malignant neoplasms

• Registration Number: DRKS00016034
• Lead Sponsor: Interdisziplinäres Zentrum Palliativmedizin Klinik und Poliklinik für Strahlentherapie Universitätsklinikum Würzburg

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2018-12-04
• Study Completion: 2020-09-10
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 169

Inclusion Criteria

oncological disease
- noticeable fatigue screening
- Ability to consent

Exclusion Criteria

- severe physical and/or psychological impairment
- insufficient German language skills
- Approach route >50km

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The primary outcome of this study is fatigue. Fatigue is measured at the beginning, after the intervention and at the 6-month follow-up for the intervention group. The waiting control group completes the questionnaire 10 weeks after the basic assessment or before the yoga intervention. Fatigue is measured with EORTC QLQ-FA13 13 Items (European Organization for Research and Treatment of Cancer - Quality of Life Questionnaire - Fatigue; Weis et al. 2017). Fatigue is measured in 3 dimensions with 13 elements: Physically, emotionally and cognitively. There are four answer categories not at all, a little, quite a lot and very much, coded with values from 1 to 4: According to the scales of the EORTC QLQ-C30, the FA13 results are converted into a range from 0-100. Higher values indicate a higher level of fatigue.

Secondary Outcome Measures

Name	Time	Method
The following secondary endpoints are measured at the beginning, after the intervention and 6 months after the intervention.<br>- Depression (PHQ9)<br>- Quality of life (EORTC QLQ-C15-PAL)<br>- Distress (distress thermometer)<br>- Symptom burden (ESAS)<br>- Sense of coherence (SOC L9)